Study Design Considerations for Drug Developers: Assessing the Feasibility of Clinical Trials from the Perspective of People Living with ALS

Time: 12:00 pm
day: Day One Track B AM


  • Defining expectations and understanding perspectives of key players in trial design (participants and caregivers, study staff, industry partners, regulatory bodies, etc.)
  • Understanding ALS: what unique challenges and strengths do this population bring to the trial design table
  • Lessons learned: review of successes, innovations, opportunities to grow, what lies ahead